Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcome of T4 (International Union Against Cancer Staging System, 7th edition) or recurrent nasal cavity and paranasal sinus carcinoma treated with proton beam.
Fukumitsu N, Okumura T, Mizumoto M, Oshiro Y, Hashimoto T, Kanemoto A, Hashii H, Ohkawa A, Moritake T, Tsuboi K, Tabuchi K, Wada T, Hara A, Sakurai H. Fukumitsu N, et al. Among authors: ohkawa a. Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):704-11. doi: 10.1016/j.ijrobp.2011.07.032. Epub 2011 Nov 16. Int J Radiat Oncol Biol Phys. 2012. PMID: 22099036
Evaluation of liver function after proton beam therapy for hepatocellular carcinoma.
Mizumoto M, Okumura T, Hashimoto T, Fukuda K, Oshiro Y, Fukumitsu N, Abei M, Kawaguchi A, Hayashi Y, Ohkawa A, Hashii H, Kanemoto A, Moritake T, Tohno E, Tsuboi K, Sakae T, Sakurai H. Mizumoto M, et al. Among authors: ohkawa a. Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e529-35. doi: 10.1016/j.ijrobp.2011.05.056. Int J Radiat Oncol Biol Phys. 2012. PMID: 22284041
Outcomes and prognostic factors for recurrence after high-dose proton beam therapy for centrally and peripherally located stage I non--small-cell lung cancer.
Kanemoto A, Okumura T, Ishikawa H, Mizumoto M, Oshiro Y, Kurishima K, Homma S, Hashimoto T, Ohkawa A, Numajiri H, Ohno T, Moritake T, Tsuboi K, Sakae T, Sakurai H. Kanemoto A, et al. Among authors: ohkawa a. Clin Lung Cancer. 2014 Mar;15(2):e7-12. doi: 10.1016/j.cllc.2013.11.002. Epub 2013 Nov 13. Clin Lung Cancer. 2014. PMID: 24365049
A multi-institutional survey of the quality of life after treatment for uterine cervical cancer: a comparison between radical radiotherapy and surgery in Japan.
Kaneyasu Y, Fujiwara H, Nishimura T, Sakurai H, Kazumoto T, Ikushima H, Uno T, Tokumaru S, Harima Y, Gomi H, Toita T, Kita M, Noda SE, Takahashi T, Kato S, Ohkawa A, Tozawa-Ono A, Ushijima H, Hasumi Y, Hirashima Y, Niibe Y, Nakagawa T, Akita T, Tanaka J, Ohno T; Working Group of the Gynecological Tumor Committee of the Japanese Radiation Oncology Study Group (JROSG). Kaneyasu Y, et al. Among authors: ohkawa a. J Radiat Res. 2021 Mar 10;62(2):269-284. doi: 10.1093/jrr/rraa107. J Radiat Res. 2021. PMID: 33415337 Free PMC article.
Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan.
Oshiro Y, Mizumoto M, Sekino Y, Maruo K, Ishida T, Sumiya T, Nakamura M, Ohkawa A, Takizawa D, Okumura T, Tamaki Y, Sakurai H. Oshiro Y, et al. Among authors: ohkawa a. Clin Transl Radiat Oncol. 2021 May 29;29:54-59. doi: 10.1016/j.ctro.2021.05.009. eCollection 2021 Jul. Clin Transl Radiat Oncol. 2021. PMID: 34151033 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 37784325
80 results